Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2013)

Celldex Therapeutics' Interest Expenses history runs 4 years deep, the most recent figure standing at $85000.0 for Q4 2013.

• In Q4 2013, Interest Expenses fell 75.78% year-over-year to $85000.0; the TTM figure through Sep 2014 stood at $85000.0 (down 92.88% YoY), while the FY2013 annual figure was $927000.0, down 41.18% from the prior year.
• Interest Expenses was $85000.0 for Q4 2013 at Celldex Therapeutics, up from $13000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $519000.0 in Q2 2013 to a low of $13000.0 in Q3 2013.
• Historically, Interest Expenses has averaged $353266.7 across 4 years, with a median of $381000.0 in 2012.
• The sharpest annual moves came in 2011 and 2013: Interest Expenses surged 31.93% in 2011, then sank 96.59% in 2013.
• A 4-year view of Interest Expenses shows it stood at $335000.0 in 2010, then soared by 30.75% to $438000.0 in 2011, then declined by 19.86% to $351000.0 in 2012, then plunged by 75.78% to $85000.0 in 2013.
• The last three Interest Expenses figures came in at $85000.0 (Q4 2013), $13000.0 (Q3 2013), and $519000.0 (Q2 2013), per Business Quant data.